ACADIA Pharmaceuticals Inc (ACAD)
16.30
-0.29
(-1.75%)
USD |
NASDAQ |
Apr 25, 12:30
ACADIA Pharmaceuticals Cash from Operations (Quarterly): 85.39M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.39M |
| September 30, 2023 | -58.96M |
| June 30, 2023 | 8.201M |
| March 31, 2023 | -17.93M |
| December 31, 2022 | -23.85M |
| September 30, 2022 | -0.727M |
| June 30, 2022 | -13.12M |
| March 31, 2022 | -76.33M |
| December 31, 2021 | -23.12M |
| September 30, 2021 | -17.06M |
| June 30, 2021 | -25.33M |
| March 31, 2021 | -60.15M |
| December 31, 2020 | -27.49M |
| September 30, 2020 | -22.79M |
| June 30, 2020 | -36.88M |
| March 31, 2020 | -49.00M |
| December 31, 2019 | -29.71M |
| September 30, 2019 | -18.85M |
| June 30, 2019 | -38.40M |
| March 31, 2019 | -64.18M |
| December 31, 2018 | -39.08M |
| September 30, 2018 | -42.28M |
| June 30, 2018 | -40.88M |
| March 31, 2018 | -45.24M |
| December 31, 2017 | -29.90M |
| Date | Value |
|---|---|
| September 30, 2017 | -58.40M |
| June 30, 2017 | -58.90M |
| March 31, 2017 | -70.56M |
| December 31, 2016 | -61.19M |
| September 30, 2016 | -49.26M |
| June 30, 2016 | -56.74M |
| March 31, 2016 | -41.21M |
| December 31, 2015 | -34.72M |
| September 30, 2015 | -31.85M |
| June 30, 2015 | -29.87M |
| March 31, 2015 | -25.35M |
| December 31, 2014 | -17.80M |
| September 30, 2014 | -17.48M |
| June 30, 2014 | -16.97M |
| March 31, 2014 | -14.18M |
| December 31, 2013 | -10.26M |
| September 30, 2013 | -9.475M |
| June 30, 2013 | -5.444M |
| March 31, 2013 | -6.585M |
| December 31, 2012 | -6.297M |
| September 30, 2012 | -5.306M |
| June 30, 2012 | -4.80M |
| March 31, 2012 | -5.23M |
| December 31, 2011 | -5.338M |
| September 30, 2011 | -4.172M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-76.33M
Minimum
Mar 2022
85.39M
Maximum
Dec 2023
-23.48M
Average
-23.85M
Median
Dec 2022
Cash from Operations (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | -22.34M |
| Amylyx Pharmaceuticals Inc | 13.55M |
| Regulus Therapeutics Inc | -6.125M |
| Minerva Neurosciences Inc | -5.991M |
| Viking Therapeutics Inc | -17.64M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.347M |
| Cash from Financing (Quarterly) | 5.434M |
| Free Cash Flow | -23.35M |
| Free Cash Flow Per Share (Quarterly) | 0.5181 |
| Free Cash Flow to Equity (Quarterly) | 85.39M |
| Free Cash Flow to Firm (Quarterly) | 85.39M |
| Free Cash Flow Yield | -0.87% |